AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts. Zhao D, Zhou Q, Zarif M, Eladl E, et al. Leuk Res 2023;134:107376.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao D, Zhou Q, Zarif M, Eladl E, et al. AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts. Leuk Res 2023;134:107376.
PMID: 37690321